Cargando…

Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes

BACKGROUND: Cardiovascular disease remains the leading cause of mortality in individuals with diabetes and improved understanding of its pathophysiology is needed. We investigated the association of a large panel of metabolites and molecular lipid species with future cardiovascular events in type 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferreira-Divino, Luis F., Suvitaival, Tommi, Rotbain Curovic, Viktor, Tofte, Nete, Trošt, Kajetan, Mattila, Ismo M., Theilade, Simone, Winther, Signe A., Hansen, Tine W., Frimodt-Møller, Marie, Legido-Quigley, Cristina, Rossing, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295441/ https://www.ncbi.nlm.nih.gov/pubmed/35850688 http://dx.doi.org/10.1186/s12933-022-01568-8

Ejemplares similares

Circulating Metabolites and Lipids Are Associated to Diabetic Retinopathy in Individuals With Type 1 Diabetes
por: Curovic, Viktor Rotbain, et al.
Publicado: (2020)

Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes
por: Tofte, Nete, et al.
Publicado: (2019)

Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes
por: Wretlind, Asger, et al.
Publicado: (2023)

Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes
por: Tofte, Nete, et al.
Publicado: (2019)

Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism
por: Hansen, Christian S., et al.
Publicado: (2022)

Carotid‐Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus
por: Tougaard, Ninna Hahn, et al.
Publicado: (2020)

Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
por: Zobel, Emilie H, et al.
Publicado: (2021)

Lipidomics of human adipose tissue reveals diversity between body areas
por: Al-Sari, Naba, et al.
Publicado: (2020)

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Bjerre-Christensen, Theis, et al.
Publicado: (2021)

Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial
por: Wretlind, Asger, et al.
Publicado: (2022)

Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials
por: Wretlind, Asger, et al.
Publicado: (2023)

High-Throughput UHPLC-MS to Screen Metabolites in Feces for Gut Metabolic Health
por: de Zawadzki, Andressa, et al.
Publicado: (2022)

42.3 METABOLOMICS APPROACHES TO STUDY METABOLIC CO-MORBIDITIES IN PSYCHOTIC DISORDERS
por: Hyötyläinen, Tuulia, et al.
Publicado: (2018)

Describing the fecal metabolome in cryogenically collected samples from healthy participants
por: Trošt, Kajetan, et al.
Publicado: (2020)

Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients
por: Ahonen, Linda, et al.
Publicado: (2019)

Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post‐hoc analysis of a randomized crossover trial
por: Al‐Sari, Naba, et al.
Publicado: (2021)

Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Tougaard, Ninna H., et al.
Publicado: (2022)

Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication
por: Israelsen, Mads, et al.
Publicado: (2021)

Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes
por: Al-Sari, Naba, et al.
Publicado: (2022)

Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes
por: Stougaard, Elisabeth Buur, et al.
Publicado: (2021)

Effect of liraglutide on expression of inflammatory genes in type 2 diabetes
por: Zobel, Emilie H., et al.
Publicado: (2021)

Assessment of the sublingual microcirculation with the GlycoCheck system: Reproducibility and examination conditions
por: Eickhoff, Mie Klessen, et al.
Publicado: (2020)

Effect of Liraglutide on Vascular Inflammation Evaluated by [(64)Cu]DOTATATE
por: Zobel, Emilie H., et al.
Publicado: (2021)

Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor
por: Rotbain Curovic, Viktor, et al.
Publicado: (2022)

Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [(64)Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial
por: Jensen, Jacob K., et al.
Publicado: (2021)

Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis
por: Suvitaival, T, et al.
Publicado: (2016)

Prediction of Type 1 Diabetes at Birth: Cord Blood Metabolites vs Genetic Risk Score in the Norwegian Mother, Father, and Child Cohort
por: Tapia, German, et al.
Publicado: (2021)

Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort
por: Andersson Svärd, Agnes, et al.
Publicado: (2020)

Linking Kidney and Cardiovascular Complications in Diabetes—Impact on Prognostication and Treatment: The 2019 Edwin Bierman Award Lecture
por: Rossing, Peter, et al.
Publicado: (2021)

Faecal biomarkers in type 1 diabetes with and without diabetic nephropathy
por: Winther, Signe Abitz, et al.
Publicado: (2021)

Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial
por: Curovic, Viktor Rotbain, et al.
Publicado: (2023)

Cost-effectiveness of targeted treatment vs chemoimmunotherapy in treatment-naive unfit CLL without TP53 aberrations
por: Slot, Matilde, et al.
Publicado: (2023)

Decreased branched-chain amino acids and elevated fatty acids during antecedent hypoglycemia in type 1 diabetes
por: She, Rui, et al.
Publicado: (2023)

Lipidomic Abnormalities During the Pathogenesis of Type 1 Diabetes: a Quantitative Review
por: Suvitaival, Tommi
Publicado: (2020)

Collagen turnover is associated with cardiovascular autonomic and peripheral neuropathy in type 1 diabetes: novel pathophysiological mechanism?
por: Hansen, Christian S., et al.
Publicado: (2023)

Deregulation of the Purine Pathway in Pre-Transplant Liver Biopsies Is Associated with Graft Function and Survival after Transplantation
por: Xu, Jin, et al.
Publicado: (2020)

Mitigating risk of aldosterone in diabetic kidney disease
por: Frimodt-Møller, Marie, et al.
Publicado: (2020)

Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease
por: Persson, Frederik, et al.
Publicado: (2019)

Multiomics signatures of type 1 diabetes with and without albuminuria
por: Clos-Garcia, Marc, et al.
Publicado: (2022)

Molecular Atlas of Postnatal Mouse Heart Development
por: Talman, Virpi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rgv9v94t646mug9c2tff35c3d7